City Therapeutics: Funding, Investors & Team (Oct 2026)
Founded by pioneering executives and scientists in RNAi, City Therapeutics is advancing next-generation engineering of small interfering RNAs (siRNAs) – the “trigger” molecules that mediate RNAi – to improve and expand the reach of RNAi-based medicines. City’s mission is to build the leading next-generation RNAi therapeutics company, unlocking RNAi’s transformative potential to help patients with a wide range of diseases.
City Therapeutics has raised $235M across 2 funding rounds on record, the most recent a Series B of $99.5M announced in Jun 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
City Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
City Therapeutics Funding Rounds
City Therapeutics raised $135M in a Series A announced in Oct 2024.
1.7 years later, a Series B of $99.5M was announced in Jun 2026.
City Therapeutics Founders and Leadership Team
Contact details for the City Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →City Therapeutics Funding Compared to Other Biotechnology Startups
City Therapeutics' latest round of $99.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like City Therapeutics in Biotechnology and Cambridge
Companies Similar to City Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
City Therapeutics Funding FAQs
What does City Therapeutics do?
Founded by pioneering executives and scientists in RNAi, City Therapeutics is advancing next-generation engineering of small interfering RNAs (siRNAs) – the “trigger” molecules that mediate RNAi – to improve and expand the reach of RNAi-based medicines. City’s mission is to build the leading next-generation RNAi therapeutics company, unlocking RNAi’s transformative potential to help patients with a wide range of diseases.
How much funding has City Therapeutics raised?
City Therapeutics has raised $235M across 2 rounds on record. The most recent is a Series B of $99.5M announced in Jun 2026.
When did City Therapeutics last raise funding?
City Therapeutics' most recent funding round on record is a Series B of $99.5M, announced in Jun 2026.
Who founded City Therapeutics?
FundedIQ lists Andy Orth (Founder), Sebastian Trousil (Founder) at City Therapeutics.
Where is City Therapeutics headquartered?
City Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does City Therapeutics have?
City Therapeutics is in the 11-50 employee band.
How does City Therapeutics' funding compare to other Biotechnology startups?
City Therapeutics' latest round of $99.5M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's City Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for City Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.